William F McDonald

William F McDonald is a seasoned biopharmaceutical professional currently serving as the Vice President and Head of Manufacturing and Supply at Verve Therapeutics, focused on gene editing therapies for cardiovascular diseases. Previously, William held the position of Vice President of CMC at OncXerna Therapeutics, overseeing technical operations for novel cancer therapies, and at ContraFect Corp, where responsibilities included managing clinical supplies for therapeutic bacteriophage enzymes. William has also been Executive Director at Celldex Therapeutics, managing internal manufacturing for monoclonal antibodies, and has experience as an independent consultant and in various leadership roles at prominent companies such as Alexion Pharmaceuticals and Pfizer. William's educational background includes a Ph.D. in Molecular Virology from Cornell University and postdoctoral fellowships in Genetics and AAV Biology.